The Trump administration is planning an Affordable Care Act replacement plan; a drug-resistant fungus has been spreading and causing severe issues for hospitals; protesters gather in Washington, DC, to criticize the FDA's handling of the opioid crisis.
Mick Mulvaney, acting White House chief of staff, says the Trump administration will release a plan to replace the Affordable Care Act “fairly shortly,” CNN reported. HHS Secretary Alex Azar and CMS Administrator Seema Verma joined White House aides and administration officials at Camp David on Saturday to outline the next moves for Trump’s healthcare proposal. Topics discussed included lowering drug prices, individual health insurance marketplaces, and messaging strategies. Mulvaney told Fox News Sunday believes the plan under development will provide GOP candidates with a plan they can discuss with voters while campaigning.
Infections caused by the fungus Candida auris, which affects people with weakened immune systems and is resistant to antifungal medications, have been quietly spreading around the world for over 5 years, The New York Times reported. The fungus was recently reported in New York, New Jersey, and Illinois after causing serious issues in Venezuela, Spain, Great Britain, India, Pakistan, and South Africa. The invasive fungus was found everywhere in the room of a patient who passed away at New York's Mount Sinai Hospital from a related infection after being hospitalized for 90 days. The hospital required special cleaning equipment and had to replace floor and ceiling tiles to fully eliminate the fungus.
Nearly 100 protesters gathered Friday in Washington, DC, to protest Scott Gottlieb, MD, on his final Day as FDA commissioner with an 800-pound heroin spoon stamped with the FDA’s logo, STAT News reported. The group called for the FDA to stop approving opioids and urged the agency to shift its focus towards encouraging the development of more drugs to treat addiction. The protesters’ chant echoed “200 dead every day, we blame the FDA.” However, the group delivered the spoon to the HHS headquarters, the Hubert H. Humphrey Building in Washington, DC, not the FDA complex in Silver Spring, Maryland.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More